Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides.

Antimicrobial Agents and Chemotherapy
J J SchentagW J Jusko

Abstract

We assessed the value of quantitative cast excretion as an early marker of renal tubular damage in 154 seriously ill patients. One hundred twenty-four of these received aminoglycoside antibiotics, and 30 of the 124 experienced a rise in serum creatinine of 0.5 mg/dl or more during therapy. The remaining 30 of the 154 patients were treated with other antibiotics and served as controls. Casts were quantitated in random urines collected before morning diuretic doses. Cast counts in control patients averaged 44 +/- 51 casts during the intensive care unit admission. Patients given aminoglycosides without a significant rise in serum creatinine of 0.5 mg/dl or more excreted 153 +/- 196 casts, significantly more than controls. In comparison to both the control and nontoxic patients, the 30 nephrotoxic patients excreted significantly more casts (625 +/- 364) and were significantly higher as early as 9 days before serum creatinine first rose. Daily urinary cast counts are a rapid and inexpensive means of identifying early renal tubular damage in critically ill patients given aminoglycosides.

References

Oct 1, 1975·Scandinavian Journal of Clinical and Laboratory Investigation·A Fredriksson
Nov 1, 1977·American Journal of Clinical Pathology·M H Haber, L E Lindner
Mar 1, 1977·Toxicology and Applied Pharmacology·W E Stroo, J B Hook
Oct 1, 1975·Annals of Internal Medicine·J R Burton, J W Rowe
Jan 1, 1978·American Journal of Clinical Pathology·G B SchumannJ B Henry
Nov 3, 1978·JAMA : the Journal of the American Medical Association·J J SchentagM E Plaut
Mar 1, 1975·Antimicrobial Agents and Chemotherapy·V PatelS A Kleit
Apr 22, 1972·British Medical Journal·P R ImhofH M Keller
Mar 1, 1957·A.M.A. Archives of Internal Medicine·G E SCHREINER
Jun 1, 1926·The Journal of Clinical Investigation·T Addis

❮ Previous
Next ❯

Citations

May 8, 2013·Nature Reviews. Nephrology·Mark A Perazella, Steven G Coca
Jul 1, 1980·Antimicrobial Agents and Chemotherapy·G H Hottendorf, L L Gordon
Jan 1, 1981·Antimicrobial Agents and Chemotherapy·M A FrenchJ J Schentag
Jun 1, 1981·Antimicrobial Agents and Chemotherapy·G H HottendorfH Madissoo
May 1, 1982·Antimicrobial Agents and Chemotherapy·J J SchentagM E Plaut
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·M AdelmanJ J Schentag
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·J M GatellM T Jimenez de Anta
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·S T Donta, L A Lembke
Oct 28, 2008·Nephron. Clinical Practice·Lakhmir S ChawlaSamir S Patel
Oct 3, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Heidi AndersenTale Norbye Wien
Apr 1, 1987·World Journal of Surgery·H J MannF B Cerra
Sep 12, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Mark A PerazellaChirag R Parikh
Jan 25, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rolando Claure-Del GranadoRavindra L Mehta
May 7, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mark A Perazella
Sep 1, 1987·Survey of Ophthalmology·K R WilhelmusM S Osato
May 1, 1989·Equine Veterinary Journal·D J EdwardsJ D Baggott
Oct 11, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K BüyükafşarA Levent
Jan 27, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tarek M El-Achkar, Xue-Ru Wu
Jan 1, 1986·Developments in Toxicology and Environmental Science·W M BennettW C Buss
Jul 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J CampsJ Rodés
Oct 23, 2019·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·João Carlos GoldaniElizete Keitel
Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·L HoffmannC Huckstorf
Aug 1, 1981·Environmental Health Perspectives·M Piscator
Aug 22, 2020·JAMA Network Open·Ragnar PalssonSushrut S Waikar
Jun 1, 1986·Drug Intelligence & Clinical Pharmacy·H J MannC A Hemstrom
Jan 1, 1986·Toxicologic Pathology·G H Hottendorf, P D Williams
Mar 1, 1990·DICP : the Annals of Pharmacotherapy·M W GarrisonJ C Rotschafer
Aug 8, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Aliyat O NafiuOluwole O Odujoko
Feb 7, 2021·Pathogens·Labrini V AthanasiouPanagiotis D Katsoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Antimicrobial Agents and Chemotherapy
A P PanwalkerG G Jackson
Antimicrobial Agents and Chemotherapy
D R SnydmanS L Gorbach
The Journal of Antimicrobial Chemotherapy
J J SchentagT J Cumbo
ORL; Journal for Oto-rhino-laryngology and Its Related Specialties
R M WalshM L Bance
© 2021 Meta ULC. All rights reserved